Aviado · Research
Longevity Daily
Saturday, April 25, 2026
Listen
Today's Brief
A growing body of evidence now links high-dose influenza vaccination to up to 40% lower Alzheimer's disease risk — making this issue's lead story one of the most actionable brain-health findings in recent memory. A counterintuitive small trial also reports that rapamycin may blunt the exercise gains older adults would otherwise see, a result that should give longevity enthusiasts serious pause. Elsewhere, 25 years of primate data confirm that caloric restriction can decouple metabolic aging from chronological time, and new research from Science Advances identifies citrulline as a key molecular brake on inflammaging.
10 stories5 peer-reviewed1 trials
Cognitive Health & Neuroprotection
High-Dose Flu Vaccination Linked to Up to 40% Lower Alzheimer's Disease Risk
A growing body of observational evidence now links influenza vaccination — particularly high-dose formulations — to up to 40% lower Alzheimer's disease risk over four years in vaccinated adults compared with unvaccinated individuals. The mechanism likely goes beyond infection prevention: researchers believe the vaccine may trigger "trained immunity," reduce age-related immune dysfunction such as inflammaging and immunosenescence, or dampen neuroinflammatory responses to amyloid pathology. Practically, requesting the high-dose flu shot if you're 65 or older may be one of the highest-leverage, lowest-effort interventions for long-term brain protection. As observational data, confounding remains possible, but the signal is consistent across multiple independent analyses.
Read more →10 Evidence-Backed Habits That Protect Brain Health, According to the Alzheimer's Association
The Alzheimer's Association's latest guidance finds that combining multiple healthy behaviors — sleep, physical activity, nutrition, and mental engagement — provides stronger brain protection than any single intervention in isolation. Even carrying genetic risk variants like APOE does not eliminate the benefit of lifestyle optimization, though genetics do meaningfully shift baseline risk. If you're already doing a few of these habits, the science suggests getting all ten into your routine stacks the odds meaningfully in your favor.
Read more →Supplements & Compounds
Citrulline Identified as a Key Molecular Brake on Inflammaging in Science Advances Study
Research published in Science Advances identifies citrulline — best known as a pre-workout supplement — as a critical endogenous regulator of inflammaging, the chronic low-grade inflammation that mechanistically drives accelerated biological aging. Declining citrulline levels with age appear to directly fuel this inflammatory phenotype, giving supplement users a compelling new reason to take it beyond athletic performance. Human dose-response data in aging populations is still limited, but this is a strong mechanistic case that will likely drive increased interest in citrulline as a longevity compound.
Read more →Dasatinib + Quercetin Outperforms Navitoclax for Clearing Senescent Cells in Disc Degeneration Model
A new mouse study directly comparing leading senolytic protocols found that dasatinib plus quercetin (D+Q) outperforms navitoclax — the more potent, cancer-derived option — for clearing senescent cells from intervertebral discs, a common driver of age-related back pain and spinal degeneration. This is one of the first head-to-head comparisons of first-generation senolytic strategies, and it favors the more accessible, lower-risk D+Q combination over riskier alternatives. The study is limited to a mouse model; human spinal senolysis data at scale remains scarce.
Read more →Research & Papers
Losartan, a Common Blood Pressure Drug, May Partially Reset the Metabolic Clock
A Johns Hopkins study published in Aging Cell used multi-omics analysis to show that losartan — a widely prescribed angiotensin II receptor blocker — reverses multiple age-related metabolic signatures in both geriatric mice and pre-frail older men. The findings position losartan as a compelling drug repurposing candidate for longevity medicine, with the added advantage of decades of established safety data already in hand. The human component draws from a small sample of pre-frail men, so broader validation is needed before this changes any prescribing or supplement decisions.
Read more →25 Years of Primate Data Confirm Caloric Restriction Resets the Biological Clock
A landmark 25-year longitudinal study of rhesus monkeys published in Molecular Systems Biology finds that caloric restriction can reset the "lipidomic clock" — the pattern of lipid changes that tracks biological aging — effectively decoupling metabolic age from chronological age. Animals maintained on CR showed lipid profiles far younger than their chronological age predicted, providing some of the strongest primate-level evidence yet that diet quantity directly shapes biological aging rate. The findings reinforce caloric or time-restricted eating as one of the most evidence-supported strategies for slowing biological aging.
Read more →Rapamycin May Blunt Exercise Gains in Older Adults, Small Trial Finds
A 40-person randomized study in adults aged 65–85 found that those taking rapamycin improved significantly less from a supervised exercise program than those on placebo — a counterintuitive result for longevity enthusiasts who rely on both strategies. The likely mechanism: rapamycin's inhibition of mTOR blunts the same anabolic signaling pathways that exercise depends on for muscle adaptation, suggesting the two interventions may partially work against each other. This is small and preliminary, but for anyone combining rapamycin with resistance training, the timing and dosing question now demands serious attention.
Read more →Lifestyle & Nutrition
Your Gut Microbiome and Physical Fitness Are Locked in a Bidirectional Relationship
Research in older adults confirms that the relationship between gut microbiome composition and physical fitness runs both ways: exercise shapes your microbiome, and your microbiome shapes your capacity to exercise — creating either a virtuous or vicious cycle as you age. Breaking that cycle therapeutically is still difficult; only fecal microbiota transplantation and flagellin immunization have been robustly shown to produce lasting compositional change, and neither is widely accessible. For now, the most actionable takeaway remains unchanged: consistent exercise is one of the most reliable tools for maintaining a younger gut microbial profile.
Read more →Obesity Is a Systemic Accelerator of Biological Aging — Not Just a Risk Factor
A comprehensive review from the University of Bologna and Drexel University argues that obesity mechanistically drives every major hallmark of aging — including cellular senescence, telomere shortening, chronic inflammation, and mitochondrial dysfunction — making it far more than a correlate of poor health outcomes. The authors reframe obesity not as a risk factor that happens to co-occur with disease, but as a direct biological accelerator that speeds aging at the cellular level regardless of other variables. For longevity optimizers, this is a forceful reminder that body composition is one of the most modifiable levers of biological age.
Read more →Industry & Policy
Oura's Acquisition Spree Reveals a Bigger Play: AI-Driven Personalized Longevity Guidance
Oura is executing a string of acquisitions aimed at building a unified AI health intelligence stack, signaling that its ambitions extend well beyond wearable hardware into real-time, personalized health guidance. The strategy reflects a broader industry bet that fragmented biometric data only becomes clinically meaningful when interpreted by AI at the individual level. Whether Oura can deliver on that promise at scale remains to be proven, but the consolidation play makes it one of the most strategically interesting companies in consumer longevity tech right now.
Read more →